David P. Hamilton

David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.

stories by David P. Hamilton

Life-science briefing: Thursday, March 27, 2008

TODAY’S HEADLINES:

Breathe Tech raises $15M for respiratory disease (release)
Protein-drug maker Pieris takes in €25M (release)
Apthera takes in $2.1M toward cancer vaccine (VentureWire)

Breathe Tech raises $15M for respiratory disease – Breathe Technologies, a Fremont, Calif., medical device …

Fast, cheap gene-scanner BioNanomatrix gets $5M

BioNanomatrix, a Philadelphia developer of genome-analysis systems, raised $5.1 million in a first funding round. Investors included Battelle Ventures, Innovation Valley Partners, KT Venture Group, Ben Franklin Technology Partners and21Ventures.

BioNanomatrix is developing a single-molecule imaging and analysis system that …

Life-science briefing: Wednesday, March 26, 2008

TODAY’S HEADLINES:

OptiMedica takes in $16M for eye-treatment lasers (release)
Genome analyzer BioNanomatrix raises $5M (release)
Heart diagnostic startup Aviir gets another $1.5M (VBLS exclusive)
Pharmaca, integrative-pharmacy chain, draws $20M (release)
LifeWatch, cardiac-monitoring device maker, withdraws IPO (IPOhome)
Jerry DeVries,

Life-science briefing: Tuesday, March 25, 2008

TODAY’S HEADLINES:

Antibody-discovery startup Adimab raises new funding (release)
Lung-device maker Spiration gets $19M (release)
Sample-prep startup Protein Discovery pulls in $10M (release)
Inogen takes in $13M for portable oxygen device (VentureWire)
Healthcare IT concern Medaptus raises $11M for expansion

Life-science briefing: Monday, March 24, 2008

TODAY’S HEADLINES:

Trius Therapeutics raises $30M for new antibiotics (release)
Genomas gets $1.2M grant for genomic side-effect tests (release)
Provasculon receives $500K, enters Biogen Idec incubator (VentureWire)
Animal diagnostics firm Quadraspec aims for $5M round (VentureWire)
MPM Capital names two

Life-science briefing: Friday, March 21, 2008

TODAY’S HEADLINES:

Cancer-vaccine maker MabVax gets $8M (release)
“Needle-free” drug maker Zogenix files for $86M IPO (Edgar)

“Needle-free” drug maker Zogenix files for $86M IPO — Zogenix, a San Diego developer of “needle-free” drug-delivery systems, has become the latest drug …

Life-science briefing: Thursday, March 20, 2008

TODAY’S HEADLINES:

Vantia Thera spins out of Ferring, raises £19M (PDF release)
Third Eye gets $150K for intracranial-pressure monitor (release)
Diabetes tester Oculir closes doors, returns capital (VentureWire)
Catalyst Health Ventures raising $60M fund (VentureWire)

Vantia Thera spins out of 

Life-science briefing: Wednesday, March 19, 2008

TODAY’S HEADLINES:

Paris-based Stentys takes $18M for “bifurcated” stents (release)
Blood analyzer IntelliDx raises $22M (PDF release)
Cancer-test biotech Calderome changes name to VeraCyte (VentureWire)
Predictive Biosciences names Peter Klemm as CEO (release)

Paris-based Stentys takes $18M for “bifurcated” stents 

Life-science briefing: Tuesday, March 18, 2008

TODAY’S HEADLINES:

Luminous Medical raises $24M for automated glucose monitoring (release)
Alimera Sciences gets $30M for eye-disease drug (release)
Vaccine maker LigoCyte draws $28M (release)
Heartbeat tracker CardioNet trims IPO, aims for listing today (IPOhome)
Axial Biotech takes in $6M

Life-science briefing: Monday, March 17, 2008

TODAY’S HEADLINES:

Defibrillator maker Cameron Health takes in $14M (VBLS exclusive)
Miramar Labs gets $20M for “aesthetic” devices (VBLS exclusive)
Nellix raises $6.5M for aneurysm grafts (VBLS exclusive)
Vessel-clog remover Chestnut Medical pulls in $7.8M (VBLS exclusive)
Consumer genetics tester

Vessel-clog remover Chestnut pulls in $7.8M

Chestnut Medical Technologies, a Menlo Park, Calif., medical-device maker, raised $7.8 million against an anticipated $10 million third funding round, I’ve learned. An SEC document (PDF link) the company filed with the California Department of Corporations disclosed the funding.

Chestnut …

Nellix raises $6.5M for aneurysm grafts

Nellix Endovascular, a Palo Alto, Calif., medical-device maker, raised $6.5 million in a third funding round, I’ve learned. The startup is developing a new treatment for repairing blood-vessel flaws in the chest and abdomen.

Those flaws, known as aneurysms, are …